EyePoint's stock offering isn't sitting well with shareholders today. Here's why.
News & Analysis: EyePoint Pharmaceuticals, Inc.
These small-cap healthcare stocks are definitely worth checking out this month.
These three biotech stocks could be great buys this month.
The growing eye industry is something investors can’t ignore.
A secondary offering raised some cash but diluted current shareholders.
EYPT earnings call for the period ending December 31, 2018.
Highlighting the day's health-care stories critical to investors.
These stocks just rolled over. Can they come back?
Eight months after its IPO, Alimera gets hammered.
These three stocks could help you swing for the fences.